JP2009184963A - Makeup cosmetic containing ubiquinone derivative and/or its salt - Google Patents

Makeup cosmetic containing ubiquinone derivative and/or its salt Download PDF

Info

Publication number
JP2009184963A
JP2009184963A JP2008026470A JP2008026470A JP2009184963A JP 2009184963 A JP2009184963 A JP 2009184963A JP 2008026470 A JP2008026470 A JP 2008026470A JP 2008026470 A JP2008026470 A JP 2008026470A JP 2009184963 A JP2009184963 A JP 2009184963A
Authority
JP
Japan
Prior art keywords
salt
makeup
cosmetic
makeup cosmetic
ubiquinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008026470A
Other languages
Japanese (ja)
Inventor
Yasushi Aoki
裕史 青木
Harumi Kamaike
晴美 蒲池
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Resonac Holdings Corp
Original Assignee
Showa Denko KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Showa Denko KK filed Critical Showa Denko KK
Priority to JP2008026470A priority Critical patent/JP2009184963A/en
Publication of JP2009184963A publication Critical patent/JP2009184963A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a makeup cosmetic making pores as inconspicuous. <P>SOLUTION: This makeup cosmetic includes a ubiquinone derivative expressed by general formula (1) [wherein, R<SP>1</SP>, R<SP>2</SP>are each independently H or a phosphoric acid group and at least one of the R<SP>1</SP>, R<SP>2</SP>is the phosphoric acid group; and (n) is an integer of 1 to 9] or its salt as an active ingredient. <P>COPYRIGHT: (C)2009,JPO&INPIT

Description

本発明は、メイクアップ化粧料に関する。より詳しくは、本発明は、皮脂による化粧崩れがし難く、継続的に用いることで毛穴が目立たなくなるメイクアップ化粧料を製造するための、特定のユビキノン誘導体またはその塩の使用、ならびにこれによって得られるメイクアップ化粧料に関する。   The present invention relates to a makeup cosmetic. More specifically, the present invention relates to the use of a specific ubiquinone derivative or a salt thereof for producing a makeup cosmetic that is difficult to disintegrate by sebum and that makes pores inconspicuous by continuous use. Related to makeup cosmetics.

化粧は、主として皮膚上に化粧料による化粧膜を形成することによって行なわれるが、様々な要因でいわゆる化粧崩れが生じるという問題がある。
化粧崩れは、汗によって皮膚上の化粧料が流れ落ちてしまうこと、皮脂の分泌によって化粧料自体が浮き上がってしまうこと、また、皮膚への物理的摩擦によって化粧膜がとれてしまうことなどによって生じる。特に小鼻や額等の皮脂分泌の盛んな部位は化粧崩れを生じやすく、また毛穴に蓄積した皮脂のために毛穴が目立ってしまうなど、美しい化粧膜を保つことが難しい。
Makeup is performed mainly by forming a cosmetic film of cosmetics on the skin, but there is a problem that so-called makeup collapse occurs due to various factors.
Cosmetic disintegration is caused by the fact that the cosmetic on the skin flows down due to sweat, the cosmetic itself rises due to the secretion of sebum, and the cosmetic film is removed due to physical friction on the skin. In particular, it is difficult to maintain a beautiful makeup film, such as a small nose or a forehead that is prone to sebum secretion, and that the pores are conspicuous due to sebum accumulated in the pores.

このような欠点を克服するために、皮脂を吸収する化粧料成分を配合するなどの方法がとられているが(特許文献1、2参照)、皮脂を吸着した化粧料自体がよれの原因になるなどして、満足な使用感は得られなかった。したがって、化粧崩れがし難い新たなメイクアップ化粧料の開発が望まれていた。
特開2005−126327号公報 特開2006−1873号公報
In order to overcome such drawbacks, methods such as blending cosmetic ingredients that absorb sebum have been taken (see Patent Documents 1 and 2), but the cosmetics that adsorbed sebum itself are the cause of kinks. As a result, a satisfactory feeling of use was not obtained. Therefore, it has been desired to develop a new makeup cosmetic that does not easily lose its makeup.
JP 2005-126327 A JP 2006-1873 A

本発明は、従来のメイクアップ化粧料に比べ、化粧崩れがし難く、継続的に用いることで毛穴が目立たなくなるメイクアップ化粧料を提供することを課題としている。   An object of the present invention is to provide a makeup cosmetic that is less likely to lose its makeup than conventional makeup cosmetics and that makes pores inconspicuous when used continuously.

本発明者らは、上記課題を解決するために、鋭意研究を重ねた結果、ユビキノン誘導体またはその塩が、皮脂分泌量を減少させ、従来より化粧崩れがし難く、継続的に用いることで毛穴が目立たなくなるメイクアップ化粧料を得ることができることを見出し、本発明を完成するに至った。   As a result of intensive studies to solve the above problems, the present inventors have found that a ubiquinone derivative or a salt thereof reduces the sebum secretion amount and is less prone to makeup collapse than before, so that pores can be continuously used. The present inventors have found that it is possible to obtain a make-up cosmetic that makes the image less noticeable.

本発明は、たとえば以下〔1〕〜〔3〕に関する。
〔1〕下記化学式(1)で示されるユビキノン誘導体および/またはその塩を含有することを特徴とするメイクアップ化粧料。
The present invention relates to, for example, [1] to [3] below.
[1] A makeup cosmetic comprising a ubiquinone derivative represented by the following chemical formula (1) and / or a salt thereof.

Figure 2009184963
(式中、R1およびR2は、それぞれ独立して水素原子またはリン酸基を表し、R1および
2の少なくとも一方はリン酸基であり、nは1〜9の整数を表す。)
〔2〕前記ユビキノン誘導体および/またはその塩が、0.0005〜50質量%の濃度で含有されていることを特徴とする〔1〕に記載のメイクアップ化粧料。
〔3〕前記式(1)におけるR1およびR2の両方がリン酸基であり、かつnが5〜9であることを特徴とする〔1〕または〔2〕に記載のメイクアップ化粧料。
Figure 2009184963
(In the formula, R 1 and R 2 each independently represent a hydrogen atom or a phosphate group, at least one of R 1 and R 2 is a phosphate group, and n represents an integer of 1 to 9).
[2] The makeup cosmetic according to [1], wherein the ubiquinone derivative and / or a salt thereof is contained at a concentration of 0.0005 to 50% by mass.
[3] The makeup cosmetic according to [1] or [2], wherein both R 1 and R 2 in the formula (1) are phosphate groups, and n is 5 to 9. .

本発明によれば、従来のメイクアップ化粧料に比べ、化粧崩れがし難く、継続的に用いることで毛穴が目立たなくなるメイクアップ化粧料が提供される。   According to the present invention, there is provided a makeup cosmetic that is less likely to lose its makeup than conventional makeup cosmetics and that makes pores inconspicuous when used continuously.

以下、本発明について具体的に説明する。
本発明に係る皮膚外用剤および化粧料は、下記式(1)で示されるユビキノン誘導体またはその塩を含有する。
Hereinafter, the present invention will be specifically described.
The external preparation for skin and cosmetics according to the present invention contain a ubiquinone derivative represented by the following formula (1) or a salt thereof.

Figure 2009184963
ただし式(1)中、R1およびR2は、それぞれ独立して水素原子またはリン酸基を表し、R1およびR2の少なくとも一方はリン酸基であり、nは1〜9の整数を表す。
Figure 2009184963
However in the formula (1), R 1 and R 2 each independently represent a hydrogen atom or a phosphoric acid group, at least one of R 1 and R 2 is a phosphoric group, n represents an integer of 1-9 To express.

前記式(1)中、R1およびR2は、それぞれ独立して、水素原子またはリン酸基を表し
、R1およびR2の少なくとも一方がリン酸基であるが、好ましくはR1およびR2の両方がリン酸基である。また、前記式(1)中、nは1〜9の整数を表すが、実用的な溶解性と皮膚親和性とをバランスよく保持させる観点から、好ましくは5〜9、より好ましくはnが9である。このうち、特に好ましくは、R1およびR2の両方がリン酸基であり、かつnが9である。
In the formula (1), R 1 and R 2 each independently represent a hydrogen atom or a phosphate group, and at least one of R 1 and R 2 is a phosphate group, preferably R 1 and R 2 Both 2 are phosphate groups. Moreover, in said Formula (1), although n represents the integer of 1-9, from a viewpoint of maintaining practical solubility and skin affinity with sufficient balance, Preferably it is 5-9, More preferably, n is 9. It is. Among these, both R 1 and R 2 are particularly preferably phosphoric acid groups, and n is 9.

このようなリン酸基修飾されたユビキノン誘導体(以下単に「ユビキノン誘導体」とも記す。)は、常法により得ることができる。たとえば、あらかじめ調製されたユビキノン類のキノンを還元してキノール型に導き、さらに常法による水酸基へのリン酸付加を行うことで合成することができる。このような方法は、米国特許2962519号などに詳細に開示されている。   Such a phosphate group-modified ubiquinone derivative (hereinafter also simply referred to as “ubiquinone derivative”) can be obtained by a conventional method. For example, it can be synthesized by reducing a quinone of a ubiquinone prepared in advance to lead to a quinol type, and further adding phosphoric acid to a hydroxyl group by a conventional method. Such a method is disclosed in detail in US Pat. No. 2,962,519.

本発明では、上記リン酸基修飾されたユビキノン誘導体の塩を用いてもよい。ユビキノン誘導体の塩とは、ユビキノン誘導体のリン酸基のアニオンとカチオンとが塩を構成するものを意味し、このようなカチオンの具体例としては、ナトリウムイオン、カリウムイオン、カルシウムイオン、マグネシウムイオン、亜鉛イオンおよびアンモニウムイオンが挙げられる。これらの中でも、皮膚外用剤、特に化粧料への配合性の点からは、ナトリウムイオンおよびカリウムイオンがより好ましい。   In the present invention, the phosphate group-modified ubiquinone derivative salt may be used. The salt of the ubiquinone derivative means that the anion and cation of the phosphate group of the ubiquinone derivative form a salt. Specific examples of such a cation include sodium ion, potassium ion, calcium ion, magnesium ion, Examples include zinc ions and ammonium ions. Among these, sodium ion and potassium ion are more preferable from the viewpoint of blendability into an external preparation for skin, particularly cosmetics.

前記ユビキノン誘導体は単独で、あるいは該ユビキノン誘導体の塩と混合した状態で用いられる。なお、以下上記ユビキノン誘導体およびその塩を総称して、「ユビキノン誘導体群」ともいう。   The ubiquinone derivative is used alone or in a mixed state with a salt of the ubiquinone derivative. Hereinafter, the ubiquinone derivatives and salts thereof are collectively referred to as “ubiquinone derivative group”.

ユビキノン誘導体群は、その水溶解性が、ユビキノン類に比べ著しく高い。たとえば、側鎖イソプレン単位の数が10であるユビキノンの水への溶解度は常温下で100ppm未満であるが、その二リン酸体の溶解度は1質量%を超える。すなわち、リン酸基修飾されたユビキノン誘導体はユビキノンに対し、優に100倍を超える水溶解性を示す。したがって、安定でかつ高濃度のユビキノン誘導体群を含有する水系製剤を容易に調製することができ、また析出などの懸念もない。しかも、水系におけるユビキノン誘導体群のラジカル消去能はユビキノンのそれより高く、より高い抗酸化能を付与したメイクアップ化粧料を実現することができる。   The ubiquinone derivative group has significantly higher water solubility than ubiquinones. For example, the solubility of ubiquinone having 10 side chain isoprene units in water is less than 100 ppm at room temperature, but the solubility of the diphosphate is more than 1% by mass. That is, the phosphate group-modified ubiquinone derivative exhibits a water solubility that is well over 100 times that of ubiquinone. Therefore, an aqueous preparation containing a stable and high concentration ubiquinone derivative group can be easily prepared, and there is no concern about precipitation. Moreover, the radical scavenging ability of the ubiquinone derivative group in the aqueous system is higher than that of ubiquinone, and a makeup cosmetic imparted with higher antioxidant ability can be realized.

メイクアップ化粧料の調製方法
ユビキノン酸誘導体および/またはその塩のメイクアップ化粧料における濃度は、特に限定する必要はなく、所望される作用の大きさに応じて設定すればよいが、概ね0.0005質量%以上、好ましくは0.001質量%以上、より好ましくは0.01質量%以上である場合に、実質的な効能を与えることができる。またユビキノン酸誘導体および/またはその塩の最大濃度には特に制限はないが、実用的な製剤としては、50質量%以下、好ましく20質量%以下、より好ましくは10質量%以下である。ただし、使用時に上記の濃度になるように、含有量50質量%以上の固形剤ならびに濃縮および分散製剤として提供される剤型を調製してもよい。
Method for Preparing Makeup Cosmetic The concentration of the ubiquinone acid derivative and / or salt thereof in the makeup cosmetic need not be particularly limited, and may be set according to the magnitude of the desired effect, but is generally about 0. When the content is 0005% by mass or more, preferably 0.001% by mass or more, more preferably 0.01% by mass or more, a substantial effect can be given. The maximum concentration of the ubiquinone acid derivative and / or salt thereof is not particularly limited, but as a practical preparation, it is 50% by mass or less, preferably 20% by mass or less, more preferably 10% by mass or less. However, a dosage form provided as a solid preparation having a content of 50% by mass or more and a concentrated and dispersed preparation may be prepared so as to have the above concentration at the time of use.

さらに、本発明においては、上記ユビキノン誘導体またはその塩を、所望により、化粧崩れ防止成分、すなわち化粧崩れを防ぐ作用を有する他の化合物と組み合わせることができる。このような成分の例としては、たとえば、皮脂吸収性粉体、皮膜形成性高分子、収斂性物質からなる群より選ばれる少なくとも1種の化合物が挙げられる。   Furthermore, in the present invention, the above-mentioned ubiquinone derivative or a salt thereof can be combined with an anti-decoration component, that is, another compound having an action of preventing the anti-decoration, if desired. Examples of such components include at least one compound selected from the group consisting of sebum-absorbing powder, film-forming polymer, and astringent substance.

皮脂吸収性粉体としては、たとえば、無水ケイ酸、多孔質シリカ、フッ素化合物処理粉体、マイカなどが挙げられる。
皮膜形成性高分子としては、たとえば、カルボキシメチルセルロース、カルボキシエチ
ルセルロースなどのセルロース誘導体、アラビアガム、でんぷん等の天然高分子およびその誘導体;アクリル酸-メタクリル酸共重合体などのアクリル系水性高分子、ポリビニル
ピロリドン、ポリエチレングリコール等の合成高分子などが挙げられる。
Examples of the sebum-absorbing powder include silicic anhydride, porous silica, fluorine compound-treated powder, and mica.
Examples of the film-forming polymer include cellulose derivatives such as carboxymethyl cellulose and carboxyethyl cellulose, natural polymers such as gum arabic and starch and derivatives thereof; acrylic water-based polymers such as acrylic acid-methacrylic acid copolymer, polyvinyl Examples thereof include synthetic polymers such as pyrrolidone and polyethylene glycol.

収斂性物質としては、たとえば、キュウリエキス、モモの葉エキス、キャロットエキス、オウゴンエキス、セージエキス、グレープフルーツ、コーヒーエキス、ハマメリスエキスなどの植物抽出物;酸化チタン、カラミン、酸化亜鉛などの金属酸化物;海塩、岩塩、塩化亜鉛、塩化アルミニウム、塩化第二鉄などの金属塩化物;乳酸、酒石酸、コハク酸、クエン酸などの有機酸などが挙げられる。   Examples of astringent substances include plant extracts such as cucumber extract, peach leaf extract, carrot extract, ougon extract, sage extract, grapefruit, coffee extract, and hamamelis extract; metal oxides such as titanium oxide, calamine, and zinc oxide. Metal salts such as sea salt, rock salt, zinc chloride, aluminum chloride and ferric chloride; organic acids such as lactic acid, tartaric acid, succinic acid and citric acid.

これらの化粧崩れ防止成分は、本発明の効果を損なわない量でメイクアップ化粧料中に含まれるように配合される。
また、本発明においては、上述した成分に加えて、所望に応じて上述した成分以外に、一般に皮膚外用剤あるいは化粧料に用いられる成分を本発明の効果を損なわない量で配合することができる。
These cosmetic breakage prevention components are blended so as to be included in the makeup cosmetics in an amount that does not impair the effects of the present invention.
In the present invention, in addition to the above-described components, in addition to the above-described components, components generally used in external preparations for skin or cosmetics can be blended in an amount that does not impair the effects of the present invention. .

配合可能な成分は特に限定されるものではなく、たとえば、化粧品原料基準第二版注解、日本公定書協会編、1984(薬事日報社)、化粧品原料基準外成分規格、厚生省薬務局審査課監修、1993(薬事日報社)、化粧品原料基準外成分規格追補、厚生省薬務局審査課監修、1993(薬事日報社)、化粧品種別許可基準、厚生省薬務局審査課監修、1993(薬事日報社)、化粧品種別配合成分規格、厚生省薬務局審査課監修、1997(薬事日報社)、化粧品原料辞典、平成3年(日光ケミカルズ)および新しい化粧品機能素材300、2002(シーエムシー出版)等に記載されている、担体、ビヒクル、または他の送達機能剤、保存剤、表面活性剤、水分保持剤、増粘剤、香料、キレート化剤、水、アルコール、抗酸化剤、殺菌剤、着色剤およびUV吸収剤などの全ての化粧品原料を使用することができる。   Ingredients that can be blended are not particularly limited. For example, cosmetic raw material standards second edition commentary, edited by Japan Public Standards Association, 1984 (Pharmaceutical Daily News), cosmetic raw materials non-standard ingredients standards, supervised by the Ministry of Health , 1993 (Pharmaceutical Daily Report), Supplement to Cosmetic Raw Material Standards, Supervised by Ministry of Health and Welfare Pharmaceutical Affairs Bureau, Examination Division, 1993 (Pharmaceutical Daily), Permitted by Cosmetic Variety, Supervised by Ministry of Health and Welfare Pharmacy Bureau, 1993 (Pharmaceutical Daily) Ingredients by cosmetic varieties, supervised by Ministry of Health and Welfare Pharmacy Examination Division, 1997 (Pharmaceutical Daily News), Cosmetic Raw Material Dictionary, 1991 (Nikko Chemicals) and New Cosmetic Functional Materials 300, 2002 (CMC Publishing) Carrier, vehicle, or other delivery function agent, preservative, surfactant, moisture retention agent, thickener, fragrance, chelating agent, water, alcohol, antioxidant, bactericidal , It is possible to use all of the cosmetics raw materials, such as colorants and UV absorbers.

本発明のメイクアップ化粧料は、上述した成分を所望の含有量となるように仕込み、得ようとするメイクアップ化粧料の剤型および形態に応じて、常法に従い、溶解、混合あるいは分散等することにより製造できる。   The makeup cosmetic of the present invention is prepared by charging the above-described components so as to have a desired content, and in accordance with the dosage form and form of the makeup cosmetic to be obtained, according to a conventional method, dissolution, mixing, dispersion, etc. Can be manufactured.

本発明のメイクアップ化粧料の剤型としては、一般的な化粧料の形態が適用され、たとえば、化粧下地、固形状または液状またはジェル状のファンデーション、チーク、口紅、コンシーラー、フェイスパウダーなどが挙げられる。   As a dosage form of the makeup cosmetic of the present invention, a general cosmetic form is applied, and examples thereof include a makeup base, solid, liquid or gel foundation, teak, lipstick, concealer, face powder and the like. It is done.

以下、実施例に基づいて本発明をさらに具体的に説明するが、本発明はこれらの実施例に限定されるものではない。また、特に断らない限り、「%」は質量%を表す。
[合成例1]ユビキノールの合成
ユビキノン(MW863.36)30gをヘキサン300mlに溶解した。溶液を室温で撹拌しながら、10%(w/v)次亜硫酸ナトリウム溶液300mlを注ぎ、さらに室温下2時間撹拌した。全量を分液ロートに移し、ヘキサン層を分取した。残った水層をさらに50mlのヘキサンで2回抽出し、先に分取したヘキサン層と合一した。このヘキサン層を脱気した飽和食塩水50mlで6回洗浄し、透明なヘキサン層を得た。ヘキサンを減圧除去した後、一昼夜窒素パージし、クリーム色の固体29.5gを得た。
EXAMPLES Hereinafter, although this invention is demonstrated further more concretely based on an Example, this invention is not limited to these Examples. Further, unless otherwise specified, “%” represents mass%.
[Synthesis Example 1] Synthesis of Ubiquinol 30 g of ubiquinone (MW863.36) was dissolved in 300 ml of hexane. While stirring the solution at room temperature, 300 ml of a 10% (w / v) sodium hyposulfite solution was poured, and the mixture was further stirred at room temperature for 2 hours. The entire amount was transferred to a separatory funnel, and the hexane layer was separated. The remaining aqueous layer was further extracted twice with 50 ml of hexane, and combined with the previously collected hexane layer. The hexane layer was washed 6 times with 50 ml of degassed saturated saline to obtain a transparent hexane layer. Hexane was removed under reduced pressure and then purged with nitrogen all day and night to obtain 29.5 g of a cream colored solid.

[合成例2]ユビキノール−1,4−ジリン酸4カリウム塩の合成
合成例1で得られた固体3gを10mlのピリジンに溶解した。溶液を寒剤(食塩/氷)浴下(−15℃)、オキシ塩化リン3.19gをピリジン5mlに溶解させた溶液を滴下し、冷却下で30分撹拌後、常温に戻し、さらに2時間撹拌した。溶液を減圧除去した後
、得られた油状物をジエチルエーテル300mlに懸濁し、飽和食塩水を150ml加え、全量を分液ロートに移し、振盪撹拌ののち静置、エーテル層を分取した。得られたエーテル層に希塩酸(濃塩酸:水=1:2)120mlを加え洗浄した後、無水硫酸マグネシウムを加えて脱水した。溶液を減圧除去し、黄色油状物2.5gを得た。これにメタノール30mlを加えて溶解させた後、水酸化カリウム0.547gをメタノール2gに溶解させた溶液を滴下した。有機溶媒を減圧除去し、さらに一昼夜窒素パージし、微黄色粉体2.63gを得た。得られた黄色粉体のNMR測定および質量分析を行い、ユビキノール−1,4−ジリン酸4カリウム塩であることを確認した。
[Synthesis Example 2] Synthesis of ubiquinol-1,4-diphosphate tetrapotassium salt 3 g of the solid obtained in Synthesis Example 1 was dissolved in 10 ml of pyridine. The solution was added in a cryogen (salt / ice) bath (−15 ° C.), a solution prepared by dissolving 3.19 g of phosphorus oxychloride in 5 ml of pyridine was added dropwise, stirred for 30 minutes under cooling, returned to room temperature, and further stirred for 2 hours. did. After the solution was removed under reduced pressure, the obtained oil was suspended in 300 ml of diethyl ether, 150 ml of saturated brine was added, the whole amount was transferred to a separatory funnel, left to stand after shaking and stirred, and the ether layer was separated. 120 ml of diluted hydrochloric acid (concentrated hydrochloric acid: water = 1: 2) was added to the obtained ether layer for washing, and then anhydrous magnesium sulfate was added for dehydration. The solution was removed under reduced pressure to give 2.5 g of a yellow oil. 30 ml of methanol was added and dissolved therein, and then a solution prepared by dissolving 0.547 g of potassium hydroxide in 2 g of methanol was added dropwise. The organic solvent was removed under reduced pressure, and further purged with nitrogen all day and night to obtain 2.63 g of a slightly yellow powder. The obtained yellow powder was subjected to NMR measurement and mass spectrometry, and confirmed to be ubiquinol-1,4-diphosphate tetrapotassium salt.

〔NMR〕
装置:Burker Advance−500
1H−NMR(D2O):δ=1.4〜1.65ppm(11H)、1.8〜1.9ppm(9H)、1.9〜2.0ppm(10H)、2.2〜2.4ppm(3H)、3.8〜4.0ppm(6H)、4.95〜5.1ppm(10H)
31P-NMR(D2O):δ=1.0−1.2ppm
〔質量分析〕
FAB−MS(−):1023(=[M−H]-
<方法>
方法:直接導入FAB−MS法
装置:JEOL JMS−SX102A
FABマトリクス:グリセリン
スキャン範囲:m/Z 50〜200
[実施例1]
1%液状ファンデーションを以下の処方に従って調製した。
[NMR]
Apparatus: Burker Advance-500
1 H-NMR (D 2 O): δ = 1.4 to 1.65 ppm (11H), 1.8 to 1.9 ppm (9H), 1.9 to 2.0 ppm (10H), 2.2 to 2 .4 ppm (3H), 3.8-4.0 ppm (6H), 4.95-5.1 ppm (10H)
31 P-NMR (D 2 O): δ = 1.0-1.2 ppm
(Mass spectrometry)
FAB-MS (−): 1023 (= [M−H] )
<Method>
Method: Directly introduced FAB-MS Method apparatus: JEOL JMS-SX102A
FAB matrix: Glycerin scan range: m / Z 50-200
[Example 1]
A 1% liquid foundation was prepared according to the following formulation.

<成分>

Figure 2009184963
[比較例1]
上記実施例1の処方よりユビキノール−1,4−ジリン酸4カリウム塩を除いた液状ファンデーションを調製した(陰性コントロール)。 <Ingredients>
Figure 2009184963
[Comparative Example 1]
A liquid foundation was prepared by removing ubiquinol-1,4-diphosphate tetrapotassium salt from the formulation of Example 1 (negative control).

[試験例1]
<使用対象および観察期間>
上記実施例1および比較例1で調製した液状ファンデーションを、20代の女性10名(被験者1〜10)に4週間使用させた。
[Test Example 1]
<Use target and observation period>
The liquid foundation prepared in Example 1 and Comparative Example 1 was used for 10 weeks by women in their 20s (subjects 1 to 10) for 4 weeks.

<使用方法>
日常の化粧法に従って、顔の一方に実施例1のファンデーションを、他方に比較例1のファンデーションを使用した。なお、各被験者には左右いずれが試験区かが判らないようにした。
<How to use>
In accordance with daily makeup, the foundation of Example 1 was used on one face and the foundation of Comparative Example 1 on the other. In addition, each subject was made not to know which side of the test area was left or right.

<効果の測定>
4週間後、顔の左右のいずれが化粧崩れし難かったか、および毛穴が目立たなくなったかを、右、左、差なし、で回答させた。実施例1のファンデーション投与区側が優れていた場合を5点、どちらも差がなかった場合を3点、比較例1のファンデーション投与区が優れていた場合を0点として評点を付けた。すべての被験者でいずれも全く差がなかった場合の評点は合計で30点となる。
<Measurement of effect>
After 4 weeks, the right, left, and no difference were answered as to which of the left and right sides of the face was difficult to collapse and whether the pores were inconspicuous. The case where the foundation administration group side of Example 1 was excellent was rated as 5 points, the case where there was no difference between them was 3 points, and the case where the foundation administration group of Comparative Example 1 was excellent was rated as 0 points. If there is no difference in all subjects, the total score is 30 points.

結果を表1に示す。   The results are shown in Table 1.

Figure 2009184963
表1から明らかなように、実施例1のユビキノール−1,4−ジリン酸カリウム塩を配合したメイクアップ化粧料は、化粧崩れがし難く、かつ継続的な使用で毛穴が目立たなくなるという、既存のものより優れた効果を示した。
Figure 2009184963
As is apparent from Table 1, the makeup cosmetic containing the ubiquinol-1,4-diphosphate potassium salt of Example 1 is difficult to break down and the pores are not noticeable with continuous use. The effect was superior to that of

Claims (3)

下記化学式(1)で示されるユビキノン誘導体および/またはその塩を含有することを特徴とするメイクアップ化粧料。
Figure 2009184963
(式(1)中、R1およびR2は、それぞれ独立して水素原子またはリン酸基を表し、R1
およびR2の少なくとも一方はリン酸基であり、nは1〜9の整数を表す。)
A makeup cosmetic comprising a ubiquinone derivative represented by the following chemical formula (1) and / or a salt thereof:
Figure 2009184963
(In Formula (1), R < 1 > and R < 2 > represent a hydrogen atom or a phosphate group each independently, R < 1 >
And at least one of R 2 is a phosphate group, and n represents an integer of 1 to 9. )
前記ユビキノン誘導体および/またはその塩が、0.0005〜50質量%の濃度で含有することを特徴とする請求項1に記載のメイクアップ化粧料。   The makeup cosmetic according to claim 1, wherein the ubiquinone derivative and / or a salt thereof is contained at a concentration of 0.0005 to 50% by mass. 前記式(1)におけるR1およびR2の両方がリン酸基であり、かつnが5〜9であることを特徴とする請求項1または2に記載のメイクアップ化粧料。 The makeup cosmetic according to claim 1 or 2, wherein both R 1 and R 2 in the formula (1) are phosphate groups and n is 5 to 9.
JP2008026470A 2008-02-06 2008-02-06 Makeup cosmetic containing ubiquinone derivative and/or its salt Pending JP2009184963A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008026470A JP2009184963A (en) 2008-02-06 2008-02-06 Makeup cosmetic containing ubiquinone derivative and/or its salt

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008026470A JP2009184963A (en) 2008-02-06 2008-02-06 Makeup cosmetic containing ubiquinone derivative and/or its salt

Publications (1)

Publication Number Publication Date
JP2009184963A true JP2009184963A (en) 2009-08-20

Family

ID=41068583

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008026470A Pending JP2009184963A (en) 2008-02-06 2008-02-06 Makeup cosmetic containing ubiquinone derivative and/or its salt

Country Status (1)

Country Link
JP (1) JP2009184963A (en)

Similar Documents

Publication Publication Date Title
JP5080249B2 (en) Novel triterpenic acid derivative and external preparation for skin containing the same
JP6599854B2 (en) Improved antiperspirant composition
JP2016145179A5 (en)
JP5846787B2 (en) Dentifrice composition
JP6125859B2 (en) Composition for external use
JP2023168621A (en) antiperspirant composition
CN108289823B (en) Oral composition
JP2005120023A (en) Skin care preparation
JP2011126788A (en) Composition for oral cavity
CN107613948B (en) Oral composition
JP2009184963A (en) Makeup cosmetic containing ubiquinone derivative and/or its salt
JP6096396B1 (en) Oral composition
KR20150121409A (en) Method for stabilizing ascorbic acid 2-glucoside and a cosmetic composition containing the stabilized ascorbic acid 2-glucoside
EP3466400B1 (en) Composition for oral cavity
JP7146389B2 (en) oral composition
JP2009184964A (en) Skin astringent containing ubiquinone derivative and/or its salt
JP2007254394A (en) Use of carnitine derivative and/or its salt for preparing makeup cosmetic
JP7333446B2 (en) oral composition
EP2813208B1 (en) Ascorbic acid derivative composition and method for producing same, ascorbic acid derivative solution, and external preparation for skin
JP6122646B2 (en) Topical skin preparation
JP6353669B2 (en) Acne-improving composition
JP6728300B2 (en) Oral composition
JP3908139B2 (en) Cosmetics
JP2009184962A (en) Deodorant skin preparation for external use
JP2007254395A (en) Use of hydroxycitric acid derivative or its salt for preparing makeup cosmetic